AI assistant
DEXCOM INC — Director's Dealing 2010
Mar 16, 2010
30198_dirs_2010-03-16_41c9d325-917c-4428-b62a-773e8d842d9d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-03-12
Reporting Person: GREGG TERRANCE H (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-12 | Common Stock | A | 146250 | $9.8 | Acquired | 629263 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: Shares are restricted and subject to repurchase by DexCom, provided that DexCom's right of repurchase lapses with respect to 1/36th of the shares each month beginning one month following the date of grant.
F2: Included in this number are 92,213 shares restricted and subject to repurchase by DexCom, provided that DexCom's right to repurchase lapses with respect to 1/30th of the shares each month beginning one month following the grant date of January 2, 2008.
F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.